SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-15-000168
Filing Date
2015-11-16
Accepted
2015-11-16 16:45:25
Documents
18
Period of Report
2015-10-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 581956
2 exhibit10-1.htm EX-10.1 127226
3 exhibit10-2.htm EX-10.2 11360
4 exhibit10-3.htm EX-10.3 10455
5 exhibit10-4.htm EX-10.4 67961
6 exhibit10-5.htm EX-10.5 68288
7 exhibit10-6.htm EX-10.6 81154
8 exhibit10-7.htm EX-10.7 62004
9 exhibit10-8.htm EX-10.8 111417
10 exhibit14.htm EX-14 40173
11 exhibit31-1.htm EX-31.1 14560
12 exhibit32-1.htm EX-32.1 6077
  Complete submission text file 0001424884-15-000168.txt   2941706

Data Files

Seq Description Document Type Size
13 tpiv-20150930.xml EX-101.INS 326273
14 tpiv-20150930.xsd EX-101.SCH 30105
15 tpiv-20150930_cal.xml EX-101.CAL 32569
16 tpiv-20150930_def.xml EX-101.DEF 85264
17 tpiv-20150930_lab.xml EX-101.LAB 205402
18 tpiv-20150930_pre.xml EX-101.PRE 157312
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 151235799
SIC: 2834 Pharmaceutical Preparations